Pemphigoid gestationis

Authors

  • María Albán Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina
  • Sabrina Meik Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina
  • María Inés Hernández Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina
  • Yanina Berberian Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina
  • Vicenta Neglia Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v31i1.2565

Keywords:

pemphigoid gestationis, herpes gestationis, rash and pregnancy

Abstract

Pemphigoid gestationis is a rare autoimmune blistering disease. It occurs in the second or third trimester and during the puerperium. It may be associated with fetal risk due to placental failure. Clinically it presents with a polymorphous and pruritic rash that starts in the periumbilical region with subsequent formation of tense blisters and variable extension. Diagnosis is based on clinical findings, histopathology and direct immunofluorescence of healthy perilesional skin.  We present the case of a 37-year-old female patient who developed pemphigoid gestationis in the third trimester of pregnancy.

Author Biographies

  • María Albán, Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina

    Medical Student, Dermatology Specialist Course, University of Buenos Aires

  • Sabrina Meik, Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina

    Staff Physician

  • María Inés Hernández, Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina

    Staff Physician

  • Yanina Berberian, Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina

    Physician, Chief Resident

  • Vicenta Neglia, Dr. Cosme Argerich General Acute Hospital, City of Buenos Aires, Argentina

    Head of the Dermatology Unit

References

I. Sävervall C, Sand FL. Thomsen SF. Pemphigoid gestationis current perspectives. Clin Cosmet Investig Dermatol. 2017;10: 441-449.

II. Genovese G, Deslino F, Cerri A, Moltrasio C, et ál. A sistematic review of treatment options and clinical outcomes in pemphigoid gestationis. Front Med. 2020;7:604945.

III. Sadik C, Lima A, Zillikens D. Pemphigoid gestationis: toward a better understanding of the etiopathogenesis. Clin Dermatol. 2016;34:378-382.

IV. Hallaji Z, Mortazavi H, Ashtari S, Nikoo A, et ál. Pemphigoid gestationis: clinical and histologic features of twenty-three patients. Int J Womens Dermatol. 2016;3:86-89.

V. Yang A, Uslenhake E, Murell D. Pemphigoid gestationis and intravenous immunoglobulin therapy. Int J Womens Dermatol. 2018;4:166-169.

VI. Lobato-Berezo A, Fernández M, Moreno J, Pujol R. Penfigoide gestacional simulando un eritema multiforme con afectación mucosa. Actas Dermo-Sifiliog. 2019;110:696-697.

VII. Sood S, Yeung J, Mufti A. Biologic therapy for refractory pemphigoid gestationis: an evidence- based systematic review. JAAD Int. 2023;13:134-136.

VIII. Al-Saif F, Elisa A, Al-Homidy A, Al-Ageel A, et ál. Retrospective analysis of pemphigoid gestationis in 32 saudi patients clinic pathological features and a literature review. J Reprod Immunol. 2016;116:42-45.

Downloads

Published

2025-04-04

Issue

Section

Clinical Cases